Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean Nationwide Study

被引:13
|
作者
Kim, Seung Jae [1 ]
Kwon, Oh Deog [2 ]
Cho, BeLong [3 ]
Oh, Seung-Won [4 ]
Lee, Cheol Min [4 ]
Choi, Ho-Chun [4 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Family Med, Seoul St Marys Hosp, Seoul, South Korea
[2] ROK Submarine Force Command, Navy Med Off, Chang Won, South Korea
[3] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul, South Korea
来源
BMJ OPEN | 2019年 / 9卷 / 06期
关键词
FIXED-DOSE COMBINATIONS; HEALTH-CARE COSTS; SINGLE-PILL; THERAPY; PERSISTENCE; NONADHERENCE; HYPERTENSION; HOSPITALIZATION; METAANALYSIS; PREVALENCE;
D O I
10.1136/bmjopen-2019-029862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We tried to clarify, by using representative national data in a real-world setting, whether single-pill combinations (SPCs) of antihypertensives actually improve medication adherence. Design A nationwide population-based study. Setting We used a 2.2% cohort (n=1 048 061) of the total population (n=46 605 433) that was randomly extracted by National Health Insurance of Korea from 2008 to 2013. Participants We included patients (n=116677) who were prescribed with the same antihypertensive drugs for at least 1 year and divided them into groups of angiotensin II receptor blocker (ARB)-only, calcium channel blocker (CCB)-only, multiple-pill combinations (MPCs) and SPCs of ARB/CCB. Primary outcome measures Medication possession ratio (MPR), a frequently used indirect measurement method of medication adherence. Results Adjusted MPR was higher in combination therapy (89.7% in SPC, 87.2% in MPC) than monotherapy (81.6% in ARB, 79.7% in CCB), and MPR of SPC (89.7%, 95% CI 89.3 to 90.0) was higher than MPR of MPC (87.2%, 95% CI 86.7 to 87.7) (p<0.05). In subgroup analysis, adherence of SPC and MPC was 92.3% (95% CI 91.5 to 93.0) vs 88.1% (95% CI 87.1 to 89.0) in those aged 65-74 years and 89.3% (95% CI 88.0 to 90.7) vs 84.8% (95% CI 83.3 to 92.0) in those >= 75 years (p<0.05). According to total pill numbers, adherence of SPC and MPC was 90.9% (CI 89.8 to 92.0) vs 85.3% (95% CI 84.1 to 86.5) in seven to eight pills and 91.2% (95% CI 89.3 to 93.1) vs 82.5% (95% CI 80.6 to 84.4) in nine or more (p<0.05). The adherence difference between SPC and MPC started to increase at five to six pills and at age 50-64 years (p<0.05). When analysed according to elderly status, the adherence difference started to increase at three to four pills in the elderly (>= 65 years) and at five to six in the non elderly group (20-64 years) (p<0.05). These differences all widened further with increasing age and the total medications. Conclusion SPC regimens demonstrated higher adherence than MPC, and this tendency is more pronounced with increasing age and the total number of medications.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Combination Antihypertensive Therapy Prescribing and Blood Pressure Control in a Real-World Setting
    Magvanjav, Oyunbileg
    Cooper-DeHoff, Rhonda M.
    McDonough, Caitrin W.
    Gong, Yan
    Hogan, William R.
    Johnson, Julie A.
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2020, 33 (04) : 316 - 324
  • [2] Real-world effectiveness of antihypertensive drugs - The authors respond
    Wright, JM
    Lee, CH
    Chambers, GK
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 162 (02) : 190 - 191
  • [3] Adherence to anticoagulant treatment with dabigatran in a real-world setting
    Schulman, S.
    Shortt, B.
    Robinson, M.
    Eikelboom, J. W.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (07) : 1295 - 1299
  • [4] Adherence to anticoagulant treatment with dabigatran in a real-world setting
    Schulman, S.
    Shortt, B.
    Robinson, M.
    Eikelboom, J. W.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 954 - 954
  • [5] Antihypertensive Medication Adherence and the Risk of Vascular Events and Falls After Stroke: A Real-World Effectiveness Study Using Linked Registry Data
    Dalli, Lachlan L. L.
    Olaiya, Muideen T. T.
    Kim, Joosup
    Andrew, Nadine E. E.
    Cadilhac, Dominique A. A.
    Ung, David
    Lindley, Richard I. I.
    Sanfilippo, Frank M. M.
    Thrift, Amanda G. G.
    Nelson, Mark R. R.
    Gall, Seana L. L.
    Kilkenny, Monique F. F.
    PRECISE Investigators
    [J]. HYPERTENSION, 2023, 80 (01) : 182 - 191
  • [6] Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group
    Han, Hye Sook
    Lee, Kyoung Eun
    Suh, Young Ju
    Jee, Hee-Jung
    Kim, Bum Jun
    Kim, Hyeong Su
    Lee, Keun-Wook
    Ryu, Min-Hee
    Baek, Sun Kyung
    Park, In Hae
    Ahn, Hee Kyung
    Jeong, Jae Ho
    Kim, Min Hwan
    Lee, Dae Hyung
    Kim, Siheon
    Moon, Hyemi
    Son, Serim
    Byun, Ji-Hye
    Kim, Dong Sook
    An, Hyonggin
    Park, Yeon Hee
    Zang, Dae Young
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [7] Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting
    Panariello, Fabio
    Kasper, Siegfried
    Zohar, Joseph
    Souery, Daniel
    Montgomery, Stuart
    Ferentinos, Panagiotis
    Rujescu, Dan
    Mendlewicz, Julien
    De Ronchi, Diana
    Serretti, Alessandro
    Fabbri, Chiara
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2023, 24 (05): : 439 - 448
  • [8] Adherence to anticoagulant treatment with dabigatran and rivaroxaban in a real-world setting
    Khalili, F. A.
    Suryanarayan, D.
    Lindstrom, C.
    Schulman, S.
    Majeed, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 117 - 117
  • [9] Adherence to anticoagulant treatment with apixaban and rivaroxaban in a real-world setting
    Al-Khalili, F.
    Lindstrom, C.
    Schulman, S.
    Majeed, A.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 544 - 545
  • [10] Medication persistence for psoriatic arthritis in a Brazilian real-world setting
    Ribeiro da Silva, Michael Ruberson
    Ribeiro dos Santos, Jessica Barreto
    Almeida, Alessandra Maciel
    Itria, Alexander
    Kakehasi, Adriana Maria
    Teodoro, Juliana Alvares
    Acurcio, Francisco de Assis
    [J]. FUTURE SCIENCE OA, 2019, 5 (02):